 | Citigroup Lowers Coherus BioSciences (NASDAQ:CHRS) Price Target to $27.00
marketbeat.com - February 25 at 2:41 PM |
 | Coherus announces start of rolling submission of Toripalimab marketing application
seekingalpha.com - March 5 at 8:01 AM |
 | Coherus BioSciences (NASDAQ:CHRS) Price Target Lowered to $29.00 at HC Wainwright
americanbankingnews.com - March 3 at 10:51 AM |
 | Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
finance.yahoo.com - March 3 at 9:30 AM |
| Coherus BioSciences (NASDAQ:CHRS) Trading Up 6.5%
americanbankingnews.com - February 26 at 7:19 PM |
| Coherus BioSciences (NASDAQ:CHRS) Price Target Cut to $29.00
americanbankingnews.com - February 25 at 6:00 PM |
| Coherus BioSciences (NASDAQ:CHRS) Price Target Cut to $27.00
americanbankingnews.com - February 25 at 4:30 PM |
| Coherus Management to Present at Upcoming Investor Conferences
finance.yahoo.com - February 25 at 1:13 PM |
| Coherus BioSciences (NASDAQ:CHRS) Releases Earnings Results, Misses Expectations By $0.13 EPS
americanbankingnews.com - February 25 at 1:00 PM |
| Coherus BioSciences Inc (CHRS) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 25 at 1:46 AM |
|
 | Coherus BioSciences (CHRS) Misses Q4 Earnings and Revenue Estimates
nasdaq.com - February 24 at 8:45 PM |
| Coherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - February 24 at 8:45 PM |
| Coherus BioSciences (NASDAQ:CHRS) Shares Down 5.2%
americanbankingnews.com - February 22 at 8:38 PM |
| Coherus BioSciences (CHRS) to Release Earnings on Wednesday
americanbankingnews.com - February 19 at 10:44 AM |
| Earnings Preview: Coherus BioSciences (CHRS) Q4 Earnings Expected to Decline
nasdaq.com - February 19 at 9:23 AM |
| Coherus BioSciences to Report Fourth Quarter and Full Year 2020 Financial Results on February 24th
finance.yahoo.com - February 18 at 8:39 AM |
| Coherus BLA Filing for Adalimumab Biosimilar Candidate Accepted by FDA for Review
finance.yahoo.com - February 17 at 9:08 AM |
| Coherus Announces CFO Transition Plans
finance.yahoo.com - February 16 at 8:49 AM |
| Did Coherus BioSciences' (NASDAQ:CHRS) Share Price Deserve to Gain 89%?
finance.yahoo.com - February 6 at 9:39 AM |
 | Coherus BioSciences, Inc.: Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
finanznachrichten.de - February 2 at 9:16 AM |
| Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
finance.yahoo.com - February 2 at 9:16 AM |
 | Peninsula biosimilar maker switches gears with $150M deal for Chinese cancer-fighting drug
bizjournals.com - February 1 at 5:18 PM |
| CHRS Crosses Below Key Moving Average Level
nasdaq.com - February 1 at 5:18 PM |
 | Coherus BioSciences to expand late-stage pipeline...
benzinga.com - February 1 at 7:16 AM |
| Coherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi Biosciences’ PD-1, toripalimab, in United States and Canada
finance.yahoo.com - February 1 at 7:16 AM |
| CHRS Feb 2021 15.000 put
au.finance.yahoo.com - January 21 at 5:25 PM |
| First Week of March 19th Options Trading For Coherus BioSciences (CHRS)
nasdaq.com - January 15 at 9:48 PM |
| CHRS Crosses Above Key Moving Average Level
nasdaq.com - January 7 at 7:47 PM |
| Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 8:25 PM |
| Coherus BioSciences, Inc. (CHRS) CEO Denny Lanfear on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 2:06 PM |
|
| Coherus BioSciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
nasdaq.com - November 7 at 12:54 PM |
| Earnings Miss: Coherus BioSciences, Inc. Missed EPS By 14% And Analysts Are Revising Their Forecasts
finance.yahoo.com - November 7 at 12:54 PM |
| Coherus BioSciences EPS beats by $0.13, misses on revenue, revised FY20 outlook
seekingalpha.com - November 5 at 6:16 PM |
 | Coherus BioSciences (CHRS) Lags Q3 Earnings and Revenue Estimates
msn.com - November 5 at 6:16 PM |
| Coherus BioSciences, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 6:16 PM |
| Coherus BioSciences Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 5 at 6:16 PM |
| Coherus BioSciences (CHRS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
finance.yahoo.com - October 29 at 2:21 PM |
| What's in Store for Perrigo (PRGO) This Earnings Season?
finance.yahoo.com - October 29 at 2:21 PM |
| CHRS or ILMN: Which Is the Better Value Stock Right Now?
finance.yahoo.com - October 26 at 1:57 PM |
| Coherus BioSciences (CHRS) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - October 26 at 1:57 PM |
| Why Coherus BioSciences (CHRS) is Poised to Beat Earnings Estimates Again
finance.yahoo.com - October 26 at 1:57 PM |
| Coherus BioSciences to Report Third Quarter Financial Results on November 5th
finance.yahoo.com - October 22 at 6:48 PM |
 | Coherus Biosciences Inc
reuters.com - September 22 at 11:41 PM |
| Coherus Has A High-Quality Business Model And Good Long-Term Potential
seekingalpha.com - September 13 at 12:27 PM |
| Our View On Coherus BioSciences' (NASDAQ:CHRS) CEO Pay
finance.yahoo.com - September 13 at 12:27 PM |
| Our View On Coherus BioSciences' (NASDAQ:CHRS) CEO Pay
finance.yahoo.com - September 13 at 12:27 PM |
| Coherus BioSciences Keeps Proving Wall Street Wrong
finance.yahoo.com - August 19 at 3:42 AM |
| Coherus BioSciences' (CHRS) CEO Denny Lanfear on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 8:38 AM |
| Coherus BioSciences (CHRS) Q2 Earnings and Revenues Top Estimates
finance.yahoo.com - August 7 at 1:40 AM |
| Coherus BioSciences EPS beats by $0.52, beats on revenue
seekingalpha.com - August 6 at 8:39 PM |
| Coherus BioSciences Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 6 at 8:39 PM |
